Reporter Oct 30 2015
Oct. 29, 2015—A compound developed by researchers at Vanderbilt University can improve early symptoms and delay progression of Huntington’s disease in a mouse model of the neurodegenerative disorder.
Oct. 29, 2015—Vanderbilt University Medical Center has received a $9.4 million grant from the National Institute on Aging (NIA) to test the effectiveness of a transdermal nicotine patch in improving memory loss in older adults with mild cognitive impairment (MCI), a precursor to Alzheimer’s disease.
Oct. 29, 2015—Nearly half of all patients with malignant melanoma, the most deadly form of skin cancer, have a mutation in the BRAF gene found in their tumors. Mutations in the BRAF gene turn on a cancer growth switch known as the MAP kinase pathway.
Oct. 29, 2015—While 12 million Americans are enrolled in health care networks through the Affordable Care Act’s (ACA) insurance marketplace, a recent study in the Journal of the American Medical Association (JAMA) raises concerns about patient access to specialists within these insurance plans.
Oct. 29, 2015—This week, Vanderbilt University Hospital (VUH) was awarded a Fall 2015 Patient Safety Grade of “A” from the Leapfrog Group, a coalition of public and private purchasers of employee health coverage that works to encourage health care safety, quality and affordability. This is the eighth consecutive time VUH has scored an “A.”
Oct. 29, 2015—Elazer Edelman, M.D., Ph.D., a pioneer in the application of engineering and physical sciences to understand fundamental biological processes and the mechanisms of disease, will deliver the next Flexner Discovery Lecture on Thursday, Nov. 5.